Posted:
#276
hahah nope ,went up to 7.22, i missed the 12 cent jump due to being sneaky, so i just bought 50 shares @ 7.22... a huge move for poopoo pants
bigFnPOO
Stock Pick - MNKD
Posted:
#281
Quote Originally Posted by nick526:
What are your thoughts on this article???? Thanks!
https://www.fool.com/investing/general/2015/02/23/3-critical-questions-mannkind-shareholders-need-to.aspx
What are your thoughts on this article???? Thanks!
https://www.fool.com/investing/general/2015/02/23/3-critical-questions-mannkind-shareholders-need-to.aspx
Nice, this Williams guy has no cred either way, no expereince. Anyone can write for the Motley Fool. I dont read their articles anymore because its some random persons opinion. His bio says he follows 1200-1500 stocks losely, I follow 10. He probably does not know much of anything about the stock or company. I did not read it but whether + or negative I would just use it as a source of opinion and do you own DD.
Posted:
#283
A poster on Yahoo MB recapped the highlights from yesterday's call. I'm very happy with what I heard. Still own a bag of 20K shares +. Also, last few days been buying the manipulated dips and then selling for some nice profits. I'll do the same today if they throw big sells together to try and take out stops and it will run back up.
Excellent call yesterday w/ a bunch of promise for the future.
If your in this and not already doing so, follow @afrezzauser on twitter. He was speaker one at adcom and took part in trials and now is using it and posts the results. Great marketer. FB, twitter, etc., are becoming a hot bed for marketing this. May see commercials in March.
This was a good summary. I have always said he has his good moments but he is still a sick b'tard.
1) Sanofi asked Mannkind to increase production of Afrezza Samples
2) Demand for Afrezza is greater than Sanofi original foretasted
3) Mannkind has identified 3 internal drug development programs for its pipeline, oncology, pain and ?
4) Mannkind has external licensing deals they are working allowing other companies to combine Mannkind technologies with their drugs
5) Mannkind 3 internal drug development programs will seek accelerated regulatory path quick approvals
6) Consultants have identified oncology as a major are to utilize technology platform that Mannkind did not have under consideration even six months ago.
7) Bank of America 9 million shares will be returned to Mannkind
8) Mannkind could have newly approved Technosphere drugs approved sooner than anyone expected.
9) $200 million in milestone payments received
10) Sanofi filed SNDA for 12U Cartridge in December and it should be approved by 2Q 2015
11) Mannkind 2 additional manufacturing lines will be up and running in the 2Q 2015,tripling capacity
12) Sanofi has initiated a soft launch of Afreza and will soon role out a 2nd major launch
13) Alfred Mann was at the conference call but did not speak
14) Mannkind will break out profit, losses & sales trends in their press release until the numbers start passing through the company's actual financial statements in the future.
15) Mannkind will stagger its 3 targeted internal development programs over several months
1) Sanofi asked Mannkind to increase production of Afrezza Samples
2) Demand for Afrezza is greater than Sanofi original foretasted
3) Mannkind has identified 3 internal drug development programs for its pipeline, oncology, pain and ?
4) Mannkind has external licensing deals they are working allowing other companies to combine Mannkind technologies with their drugs
5) Mannkind 3 internal drug development programs will seek accelerated regulatory path quick approvals
6) Consultants have identified oncology as a major are to utilize technology platform that Mannkind did not have under consideration even six months ago.
7) Bank of America 9 million shares will be returned to Mannkind
8) Mannkind could have newly approved Technosphere drugs approved sooner than anyone expected.
9) $200 million in milestone payments received
10) Sanofi filed SNDA for 12U Cartridge in December and it should be approved by 2Q 2015
11) Mannkind 2 additional manufacturing lines will be up and running in the 2Q 2015,tripling capacity
12) Sanofi has initiated a soft launch of Afreza and will soon role out a 2nd major launch
13) Alfred Mann was at the conference call but did not speak
14) Mannkind will break out profit, losses & sales trends in their press release until the numbers start passing through the company's actual financial statements in the future.
15) Mannkind will stagger its 3 targeted internal development programs over several months
Posted:
#288
Quote Originally Posted by Pipe-Light:
Way way to risky now.... Although who knows why it is being pushed here....
Its FDA approved and Sanofi is doing a soft launch, soon to be a full launch along with their newly approved Toujeo. Not as arisky as when I bought in and watched it run to 12 and held. It was not even done testing. Now is the easy part
Posted:
#290
Quote Originally Posted by BIGfnPOO:
i thght it would drop last week, i bought at 7.27 a day or 2 before it plunged to 5.70. its ok..
better days coming louis.
i thght it would drop last week, i bought at 7.27 a day or 2 before it plunged to 5.70. its ok..
better days coming louis. We just have to sit tight and take it square in the a hole while Goldman makes money on the short and then buys all back and rides it up LONG. Its due or die time in next year or so because sales is what counts and further promo of Technosphere. I'm done buying, maxed out.
Posted:
#293
Quote Originally Posted by logicalbetting:
Hey Louis,
Do you think it has bottomed out here or a chance to still drop. I want to jump in and have been watching it since you have posted and now have the funds to do so.
Thanks
You have to understand first off I firmly believe in Alfred Mann and Mannkind Corp. I believe they will ensure success and to this point have hit all their targets with Afrezza getting to market. I can't believe the PPS is this LOW. Its one of the most shorted stocks in the market % wise (means people are betting it drops). The % never changes. There is a lot of attention on this stock by Funds and by competitors. They are trying to keep it down but in time the numbers will show how great this is for diabetics. Unless this thing gets completely manipulated down I cant see how buying here in mid-5's is not a great investment. So much more upside then down. Need patience (I even do) and I been in awhile.
Good luck. Note. We could see 4's or even 3's but then it could fly up a few bucks in a day later this year. Good value here I think, just my view.
Posted:
#294
Quote Originally Posted by BIGfnPOO:
louis, in case it hits 5.00 again next week. i have a order in to buy @ 5$.thx for the action.
louis, in case it hits 5.00 again next week. i have a order in to buy @ 5$.
thx for the action.Your order to buy 100 share(s) of MANNKIND CORP (MNKD) was placed on 3/05/2015 at 3:01:18 PM ET.
Seems like a nice BUY, hope we don't get there though, but have to see, there shaking out the weak hands and big boys are buying in low to prepare for run. Short it down, run it up.
Posted:
#298
I like this line from KK :
"When choosing between competing views on a stock, I find its almost always better to pay more attention to the person with the better track record. I don’t know the track record of the Goldman analyst who made the recommendation to sell, but I do know Nate’s track record and I am comfortable following his lead."
Posted:
#299
I'll take Nate hands down
Sanofi just hired Olivier Brandicourt as there new CEO. Oliver Brandicourt worked at phizer.
Jay Olson, the Goldman anlayst who downgraded mannkind (afrezza) which is now being managed by sanofi used to work at phizer
From what I read, Olson was canned by Brandicourt from Phizer.
So the downgrade means doo-doo.
Nate is smart.
Hot Forum Topics
